1 |
Pearson SD, Patel BK. Evolving targets for sedation during mechanical ventilation[J]. Curr Opin Crit Care, 2020, 26 (1): 47-52.
|
2 |
Chanques G, Constantin JM, Devlin JW, et al. Analgesia and sedation in patients with ARDS[J]. Intensive Care Med, 2020, 46 (12): 2342-2356.
|
3 |
Vincent JL, Shehabi Y, Walsh TS, et al. Comfort and patient-centred care without excessive sedation: the eCASH concept[J]. Intensive Care Med, 2016, 42 (6): 962-971.
|
4 |
Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU[J]. Crit Care Med, 2018, 46 (9): e825-e873.
|
5 |
Casault C, Soo A, Lee CH, et al. Sedation strategy and ICU delirium: a multicentre, population-based propensity score-matched cohort study[J]. BMJ Open, 2021, 11 (7): e045087.
|
6 |
Garcia R, Salluh JIF, Andrade TR, et al. A systematic review and meta-analysis of propofol versus midazolam sedation in adult intensive care (ICU) patients[J]. J Crit Care, 2021 (64): 91-99.
|
7 |
Shi HJ, Yuan RX, Zhang JZ, et al. Effect of midazolam on delirium in critically ill patients: a propensity score analysis[J]. J Int Med Res, 2022, 50 (4): 3000605221088695.
|
8 |
Miyagawa N, Kawazoe Y, Sato T, et al. Comparison between midazolam and propofol in acute phase for ventilated patients with sepsis: a post-hoc analysis of the DESIRE trial[J]. Acute Med Surg, 2022, 9 (1): e746.
|
9 |
Lewis K, Alshamsi F, Carayannopoulos KL, et al. Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials[J]. Intensive Care Med, 2022, 48 (7): 811-840.
|
10 |
Ding HZ, Dong YL, Zhang KY, et al. Comparison of dexmedetomidine versus propofol in mechanically ventilated patients with sepsis: a meta-analysis of randomized controlled trials[J]. Front Pharmacol, 2022 (13): 901898.
|
11 |
Stangaciu B, Tsotsolis S, Papadopoulou S, et al. Sedation with dexmedetomidine in critically ill burn patients reduced delirium during weaning from mechanical ventilation[J]. Cureus, 2022, 14 (11): e31813.
|
12 |
Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial[J]. JAMA, 2009, 301 (5): 489-499.
|
13 |
Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials[J]. JAMA, 2012, 307 (11): 1151-1160.
|
14 |
Zhou Y, Yang J, Wang B, et al. Sequential use of midazolam and dexmedetomidine for long-term sedation may reduce weaning time in selected critically ill, mechanically ventilated patients: a randomized controlled study[J]. Crit Care, 2022, 26 (1): 122.
|
15 |
Dabrowski W, Siwicka-Gieroba D, Gasinska-Blotniak M, et al. Pathomechanisms of non-traumatic acute brain injury in critically ill patients[J]. Medicina (Kaunas), 2020, 56 (9): 469.
|
16 |
徐荣鹏,杨春,朱滨. ICU谵妄的研究进展[J].中华危重病急救医学,2020,32(5):636-640.
|
17 |
Dziegielewski C, Skead C, Canturk T, et al. Delirium and associated length of stay and costs in critically ill patients[J]. Crit Care Res Pract, 2021 (2021): 6612187.
|
18 |
Vasilevskis EE, Chandrasekhar R, Holtze CH, et al. The cost of ICU delirium and coma in the intensive care unit patient[J]. Med Care, 2018, 56 (10): 890-897.
|
19 |
Girard TD, Thompson JL, Pandharipande PP, et al. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study[J]. Lancet Respir Med, 2018, 6 (3): 213-222.
|
20 |
Su X, Meng ZT, Wu XH, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-ardiac surgery: a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2016, 388 (10054): 1893-1902.
|
21 |
Reade MC, Eastwood GM, Bellomo R, et al. Effect of dexmedetomidine added to standard care on ventilator free time in patients with agitated delirium: a randomized clinical trial[J]. JAMA, 2016, 315 (14): 1460-1468.
|
22 |
Hughes CG, Patel MB, Brummel NE, et al. Relationships between markers of neurologic and endothelialInjury during critical illness and long-term cognitive impairment and disability[J]. Intensive Care Med, 2018, 44 (3): 345-355.
|
23 |
Erikson K, Ala-Kokko TI, Koskenkari J, et al. Elevated serum S-100β in patients with septic shock is associated with delirium[J]. Acta Anaesthesiol Scand, 2019, 63 (1): 69-73.
|
24 |
Ye C, Zhang Y, Luo S, et al. Correlation of serum BACE1 with emergence delirium in postoperative patients: a preliminary study[J]. Front Aging Neurosci, 2020 (12): 555594.
|
25 |
Anderson BJ, Reilly JP, Shashaty MGS, et al. Admission plasma levels of the neuronal injury marker neuron specific enolase are associated with mortality and delirium in sepsis[J]. Crit Care, 2016 (36): 18-23.
|
26 |
惠姣洁,严正,梁锋鸣,等.血浆BDNF、NSE和S100β的动态变化与ICU患者谵妄的关系[J].中华急诊医学杂志,2018,27(10):1132-1135.
|
27 |
Li Y, Yu ZX, Ji MS, et al. A pilot study of the use of dexmedetomidine for the control of delirium by reducing the serum concentrations of brain-derived neurotrophic factor, neuron-specific enolase, and S100B in polytrauma patients[J]. J Intensive Care Med, 2019, 34 (8): 674-681.
|